The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Keep reading to learn about Medicare coverage and eligibility for Inspire and other sleep apnea devices and your possible out-of-pocket costs. Inspire is an implanted hypoglossal nerve stimulation ...

Nyxoah’s Investor Presentation can be accessed on the Shareholder Information section of the Company’s Investor Relations page.

The U.S. market launch of Genio® is fully funded following the successful raising of over €85 million in growth capital ...

2024 to recognize the Company’s recent progress and highlight upcoming milestones on its path to the U.S. market launch of its innovative patient-centric Genio® hypoglossal nerve stimulation ...

The company has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. A significant body ...

Sleep apnea does not go away on its own, although some of the conditions and structural factors that cause it can be treated and reversed. For instance, a septoplasty can fix a deviated septum that is ...

But we also prescribe the hypoglossal nerve implant – more commonly known as Inspire, the name of the company that developed the technology. This device helps control sleep apnea in patients who ...